Literature DB >> 7512837

A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors.

L A Milner1, R Kopan, D I Martin, I D Bernstein.   

Abstract

Members of the Notch gene family have been shown to mediate cell-fate decisions by multipotent precursors in a number of different systems. To determine whether members of this family might play a similar role in hematopoiesis, we asked if homologues of the Notch gene are expressed in human hematopoietic precursors. Using degenerate oligonucleotides corresponding to conserved amino acid sequences in known Notch homologues as primers for the polymerase chain reaction (PCR), we demonstrated that at least one Notch homologue is expressed in human bone marrow CD34+ cells, a population enriched for hematopoietic precursors. Cloning and sequencing of the PCR products identified this Notch homologue as TAN-1, a member of the Notch family previously cloned from a T-cell leukemia with a translocation involving this gene. Subsequent evaluation of bone marrow hematopoietic cells for TAN-1 expression using a reverse transcription-PCR assay confirmed the expression of TAN-1 in CD34+ hematopoietic precursors, including the immature subset that lacks expression of lineage-associated antigens (CD34+lin-). These findings, together with the known role of Notch homologues in other systems, suggest that members of the Notch family, including TAN-1, may be involved in mediating cell-fate decisions during hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512837

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Notch signalling via RBP-J promotes myeloid differentiation.

Authors:  T Schroeder; U Just
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  The notch pathway: modulation of cell fate decisions in hematopoiesis.

Authors:  K Ohishi; B Varnum-Finney; I D Bernstein
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

3.  Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells.

Authors:  Kohshi Ohishi; Barbara Varnum-Finney; Irwin D Bernstein
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

4.  Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells.

Authors:  Colleen M Witt; Vincent Hurez; C Scott Swindle; Yoshio Hamada; Christopher A Klug
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2.

Authors:  A J Capobianco; P Zagouras; C M Blaumueller; S Artavanis-Tsakonas; J M Bishop
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

Review 6.  Prostate epithelial stem cells.

Authors:  S Rizzo; G Attard; D L Hudson
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

Review 7.  Notch signaling in hematopoietic stem cells.

Authors:  Takahiro Suzuki; Shigeru Chiba
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

8.  Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis.

Authors:  I Cortegano; P Melgar-Rojas; L Luna-Zurita; M Siguero-Álvarez; M A R Marcos; M L Gaspar; J L de la Pompa
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

9.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development.

Authors:  Brandon K Hadland; Stacey S Huppert; Jyotshnabala Kanungo; Yingzi Xue; Rulang Jiang; Thomas Gridley; Ronald A Conlon; Alec M Cheng; Raphael Kopan; Gregory D Longmore
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.